The PRP4 protein of Saccharomyces cerevisiae is an essential part of the U4/U6 snRNP, a component of the mRNA splicing apparatus. As an approach to the determination of structure-function relationships in the PRP4 protein, we have isolated more than fifty new alleles of the PRP4 gene through random and sitedirected mutagenesis, and have analyzed the phenotypes of many of them. Twelve of the fourteen single-point mutations that give rise to temperaturesensitive (ts) or null phenotypes are located in the portion of the PRP4 gene that corresponds to the (3-transducin-like region of the protein; the remaining two are located in the central portion of the gene, one of them in an arginine -lysine-rich region. Nine additional deletion or deletion/insertion mutations were isolated at both the amino-and carboxy-termini. These data show that the amino-terminal region (108 amino acids) of PRP4 is non-essential, while the carboxy-terminal region is essential up to the penultimate amino acid. A deletion of one entire /3-transducin-like repeat (the third of five) resulted in a null phenotype. All ts mutants show a first-step defect in the splicing of U3 snRNA primary transcript in vivo at the non-permissive temperature. The effects on prp4 mutant growth of increased copy-number of mutant prp4 genes themselves, and of genes for other components of the U4/U6 snRNP (PRP3 and U6 snRNA) have also been studied. We suggest that the PRP4 protein has at least three domains: a non-essential amino-terminal segment of at least 108 amino acids, a central basic region of about 140 residues that is relatively refractile to mutation and might be involved in RNA interaction, and an essential carboxy-terminal region of about 210 residues with the five repeat-regions that are similar to /3-transducins, which might be involved in proteinprotein interaction. A model of interactions of snRNP components suggested by these results is presented.
INTRODUCTION
The spliceosome, a ribonucleoprotein structure which is required for pre-messenger RNA (pre-mRNA) splicing in all eukaryotes, is composed of the pre-mRNA, five species of small nuclear ribonucleoprotein particle (snRNP) and associated factors (1) (2) (3) (4) (5) (6) (7) . The snRNPs consist of five different species of small nuclear RNA (snRNA; reviewed in 8) and a large number of proteins (reviewed in 1, 7, 9-12), some of whose functions are beginning to be understood.
Knowledge of the protein components of the spliceosome has come primarily from biochemical studies in HeLa cells and genetic studies in the budding yeast, Saccharomyces cerevisiae. The former have revealed the so-called core or Sm proteins that are common to four of the five snRNPs (Ul, U2, U4 and U5; reviewed in 4). These proteins, along with the trimethylguanosine cap that is found on the 5'-terminus of most snRNAs, have been implicated in the transport of assembled snRNPs from cytoplasm to nucleus (13, 14) . Proteins that are specific for the Ul, U2, and U5 snRNPs, as well as for the U4/U6 di-snRNP, have also been found in HeLa cells (1, (9) (10) (11) (12) 15) . In particular, the Ul 70K, A, and U2 B" proteins of HeLa have been studied both biochemically and structurally; these proteins have a sequence that has been implicated in the binding of some proteins to RNA (16, 17) . Homologues of the Ul 70K (18) and A (19) proteins have been found in yeast.
Genetic studies in yeast have identified at least thirty PRP (precursor RNA processing) (6, 7) genes, many of which are temperature-sensitive (ts) both for cell growth and mRNA splicing. Their participation in splicing has been studied both in vivo and in vitro. Some of these gene products are involved in specific steps of the splicing process: PRP9 (20) , PRP21 (21, 22) and PRP5 (23) act in spliceosome assembly; PRP2 acts on assembled spliceosomes in the presence of ATP and other factors in the first step of the splicing reaction (24) ; PRP19 also acts early in the spliceosome assembly process (22) ; PRP 16 (25) and PRP 18 (26) are required in the second step, and PRP22 (27) in release of the spliced mRNA from the spliceosome. PRP17/SLU4 and SLU7 appear to be involved in 3'-splice-site selection (28, *To whom correspondence should be addressed "•"Present address: Department of Cancer Biology, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH, USA 29). A yeast de-branching activity is associated with DBR/PRP26 (30) ; presumably this is a late step, following or concomitant with the splicing reactions.
Some of the PRP proteins have structural motifs that suggest their function. For example, six splicing-related proteins in yeast, PRP2, 5, 16, 22, 28 and SPP81 have amino acid motifs that are associated with proteins which have RNA-dependent ATPase activity and/or ATP-dependent RNA-helicase activity (23, 27, (31) (32) (33) (34) , suggesting that conformational changes in RNA are crucial events in most steps of mRNA splicing. To date, PRP2 and PRP 16 have been shown biochemically to possess RNAdependent ATPase activity (35, 36) . PRP4 and PRP 17 have a repeated amino acid motif with similarity to /3-transducins (4, 7, 37) ; whose significance is not yet understood. Three gene products have an RNA-binding consensus, PRP24 (38) , MUD1 (19) and SNP1 (39) ; the latter is a yeast homologue of the HeLa Ul 70K protein. At least two of the PRP gene products, PRP11 (40) and PRP 19 (41) , have been shown to be associated with the spliceosome, but not yet with a particular snRNP. Several other PRP proteins are known to be associated with a specific snRNP: PRP8 with U5 (42), PRP3 (J.Woolford, personal communication), PRP4 (43, 44) , PRP6 (20) and PRP24 (38) with the U4/U6 snRNP, and SNP1 (39) and MUD1 (19) with the Ul snRNP.
The PRP4 gene product is the first protein identified as a component of the U4/U6 snRNP (43, 44) . Using a combination of RNase H digestion and immunoprecipitation it was shown that this protein is found in association with the 5'-portion of U4 snRNA, although association with U6 snRNA was not ruled out completely (45) . Deletion of the 5'-stem-loop of the U4 snRNA abolished association of the PRP4 protein with the U4/U6 snRNP (46) . Neither of these studies demonstrate the direct binding of PRP4 to U4 snRNA. The PRP4 gene product is a 52 kDa protein of 465 amino acid residues (43, 44) . Its primary amino acid sequence indicates a structure of five repeats that are similar to repeats in the /3-subunit of bovine transducin, as well as the yeast STE4, CDC4 gene products, and other /3-subunits of the G-protein family (37) . The function of the /3-transducin-like sequences is not known. A second structural feature of the PRP4 protein is an acidic stretch in the amino-terminal portion, located between amino acids 99-108 and consisting of a stretch of nine Glu and Asp residues with only one non-charged amino acid in it. A third, central, region of the PRP4 protein is basic.
The role in mRNA splicing of the PRP4 protein, or for that matter of the U4 snRNP, is not yet understood. As a step in defining that role, we report here the results of a genetic dissection of the PRP4 gene product using random and site-directed mutagenesis. We have isolated more than fifty prp4 mutations, of which thirty-seven have been sequenced and partially characterized. These studies indicate that the amino-terminal 108 residues, including the acidic stretch, are non-essential for PRP4 function; that the /3-transducin-like segment is essential, although with a surprising degree of tolerance for replacement of residues in the most conserved amino acids of this motif; and that the central segment of PRP4 is also important for function, since mutations in this region cause severe impairment of growth. Cells carrying one of several ts alleles of prp4 show a significantly decreased level of U6 snRNA at the non-permissive temperataure, suggesting a role for either PRP4 or the U4 snRNP in assembling or stabilizing the U6 snRNP.
MATERIALS AND METHODS

Yeast strains, plasmids and media
LP112 (Mata/a canl-lOO/canl-100
Ms3-ll,15/his3-U,15 Ieu2-3,112/leu2-3,112 trpl-l/trpl-1 ura3-l/ura3-l ade2-ll de2-l) is an isogenic diploid strain provided by R.Rothstein. W3O3-1A (Mata) is a haploid form of strain LP112. The null allele of prp4 (prp4::HIS3 strain YF1582) was constructed as described previously (44) . prp4-l was integrated into the chromosome of strain W3O3-1A as follows. An integrative, URA3 plasmid (pFL34, given to us to by F.Lacroute) was targeted to the chromosome at the PRP4 locus. 5-flouro-orotic acid (5-FOA)-resistant derivatives were isolated and were screened for temperature-sensitive (ts) phenotype. The ts phenotype was verified as being due to a mutation at the prp4 locus by introducing a PRP4-containing plasmid and observing that the phenotype reverted to wild-type; this strain is called YF1634. The prp3-l mutant strain (Mata adel Ieu2 his7prp3-l) was given to us by J.Woolford, and the prp6-l mutant strain (Mata adel Iys2 ura3-52 prp6-1) by M.Rosbash.
The following plasmids were used. pBC ks+ (Stratagene,
pJAYlOO {TRPl-pGALl-CEN6-ARS (based on pFL39; derived by F.Lacroute and J.Archambault), pEMBLYEX4 (2-^im-URA3-pGAL10). The following plasmids were constructed for this study: pYXl 12 has the PRP3 gene driven by pGALlO on pJAYlOO (J.Archambault). pYX172 has the U6 snRNA gene under the control of its normal promoter and carried on YEP 13. pYXl 17 has the U6 snRNA gene under the control of its normal promoter and carried on YEP24; the U6 snRNA gene was isolated from the yeast genome by using the polymerase chain reaction (PCR) with two U6 snRNA-gene-specific oligonucleotide primers. pYF1378 has the U4 snRNA gene under the control of its normal promoter and carried on YEP13; pYX185 is the same, but is carried on YEP24. pYW4 was constructed by inserting the PRP4 coding region into pEMBLYEX4 between the Xbal and and //mdffl sites; a sequence (GGCCATCATCAT-CATCATCATCATCATCATCACAGCAGCGGCCATATC-GAAGGTCGTCATATGCTCGATCGAGGATCC) encoding ten histidine residues was inserted immediately downstream of the first ATG codon of PRP4.
Yeast growth media were described previously (48) . Growth temperatures are indicated in the text. Plasmids were propagated in E.coli JF1754 (44) or JM101. M13 clones were propagated in E.coli JM101. Single-stranded DNA templates for site-directed mutagenesis were isolated from E.coli strains CJ236 or RZ1032.
The prp4-l mutant strain (ts 339; 49) was obtained from the Yeast Genetic Stock Center, Berkeley, CA. Total chromosomal DNA was digested with Hindm, fractionated on a 5-20% sucrose gradient, and DNA in the range of 1.5-4.0 kilobases (kb) was pooled and concentrated by precipitation. These DNA fragments were cloned into the HindUl site of pUC18. This library was introduced into E.coli and the colonies were probed with oligonucleotides specific for the PRP4 gene in order to select the correct plasmid construct. Mutants prp4-2 and 4-3 were obtained from L.Hartwell. The mutant gene sequences were amplified directly from the genome of the original strains by using PCR (50) and oligonucleotide primers that span codons 75-80 and a region 210 bp downstream of the stop codon; two independent PCR products from each mutation were sequenced.
The various prp4 mutant genes were placed under the control of the GAL10 promoter (pGALlO) by ligating a 1.63 kb Seal-Hindill fragment from the appropriate mutant-bearing plasmid (see below) into HincE-HindlU. sites downstream of pGALlO in pJAYlOO.
Yeast transformation was carried out as described (51) . All DNA manipulations were done according to conventional procedures (50) .
PRP4 antibody production and use
For production of antibody against PRP protein, the PRP4 coding sequence was cloned into the BamHl site of pAR3038, which contains a T7 promoter (52) . The resulting plasmid, pKSR4 was introduced into E.coli BL21(DE3). Two liters of transformed cells were grown at 37°C and induced (at ODgoo = 0.5) with 1 mM IPTG for 3 h at the same temperature. The cells were harvested by centrifugation at 6,000 xg for 10 min and resuspended in 200 ml of 100 mM NaCl, 1 mM EDTA, 50 mM Tris-HCl, pH 8.0. Following addition of lysozyme to 1 mg/ml and phenylmethylsulfonyl fluoride to 1 mM, the cell suspension was incubated at room temperature for 20 min. The cells were collected again by centrifugation and the cell membranes were disrupted by resuspension in the same buffer plus 1 % Triton X-100 and 1 % Tween-20, then freezing and thawing three times in dry ice-ethanol and 37°C water baths. The cellular DNA and RNA were digested by adding MgCl 2 to 8 mM, DNase I to 10 /ig/ml and RNase A to 1 ^g/ml. The inclusion bodies were collected by centrifugation at 8,000 Xg for 10 min and were resuspended in the same buffer containing 25% sucrose, 1% Triton X-100 and 1% Tween-20. The insoluble PRP4 protein was collected by centrifugation again and further purified by using a Prep-Cell (BIO-RAD). Two rabbits were injected subcutaneously with 100 fig of the purified PRP4 protein and were boosted four times each with the same amount of protein at one-month intervals.
The crude antisera from both rabbits were found to be highly specific when used for immunoprecipitation. In order to decrease the background for protein blots, and since the specific antibodies against PRP4 are expected to be in excess compared to the levels of the non-specific antibodies, total yeast proteins were used to absorb an antibody solution. This was done by immobilizing 5 mg of yeast proteins on a polyvinylidene difluoride (PVDF) membrane (5 X10 cm) and incubating the membrane with 50 fi\ of antiserum in 10 ml of 10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.1% Tween-20 (TBST ) at 4°C for 1 h after blocking die membrane with 5 % Carnation instant milk powder in TBST at room temperature for 1 h. The treated antibody solution was saved and used for immunoblotting following an additional 100-fold dilution.
Isolation of random and site-directed PRP4 mutations
Random mutagenesis was carried out as follows. Plasmid pYF423 (LEU2-2-fim-PRP4; 53) was treated with /V-methyl-Nnitrosoguanidine as described (53) . DNA was prepared in purified form for introduction into strain YF1582, which has a null mutation of prp4 (PRP4::HIS3) as the sole chromosomal copy, and the normal PRP4 function supplied on a URA3-PRP4-CEN-ARS plasmid (pYF1043). Following transformation of this strain with a library of mutagenized PYF423 DNA and growth for many generations on Leu-His-Ura drop-out medium, mutant cells were diluted and grown overnight at 23°C on Leu-His dropout medium. These were spread on solid medium, grown at 23 °C and then were patched on solid Leu-His drop-out medium containing 1 mg/ml 5-FOA, which selects for cells that have lost the PRP4-URA3 maintenance plasmid. Surviving colonies were replica-patched onto 5-FOA-solid medium and were grown at different temperatures; those with temperature-sensitive (ts) or no-growth (null) phenotypes were retained. Plasmids were recovered from these strains by conventional methods, passed through E.coli, and were re-introduced into yeast strain YF1582 (PRP4::HIS3) in order to confirm the plasmid-related phenotype. Those plasmids that survived this test were retained for further analysis.
Site-directed mutations were constructed by conventional methods (50), using PRP4 carried on bacteriophage M13. All mutations were verified by sequence analysis. Mutant genes were then transferred to plasmid pRS315 or pSB32 (LEU2-CEN-ARS) to be introduced into yeast for further analysis.
RNA blots and primer-extension analysis
RNA blots were done with total cellular RNA as described previously (44) . Primer-extension analysis was done with 5 /tg of total yeast RNA per sample. This was hybridized to 2 ng of 7-32 P-ATP-labelled, U3 snRNA-specific and U2 snRNAspecific (as loading control) oligonucleotide in a buffer consisting of 50 mM Tris-HCl, pH 8.0, 40 mM NaCl and 0.5 mM EDTA in a total of 15 /i\ (54) . Hybridization was carried out at 65 °C for 5 min, then 52°C for 30 min. Following this 2.5 units of AMV reverse transcriptase (BRL) in a buffer consisting of 0.7 mM dNTPs, 30 mM MgCl 2 , 3 mM dithiothreitol and 0.6 /ig//tl actinomycin D in a total of 50 fil was added and the mixture was incubated for 1 h at 42°C. Following phenol extraction the reaction products were applied to a 6% denaturing polyacrylamide gel.
Yeast protein preparation and immunoblot analysis
Wild-type and mutant PRP4 strains were grown in selective medium at 23°C. The cultures were shifted to 37°C (at OD= 0.3-0.4) for 2 h. Total yeast proteins from 100 ml cultures were prepared as described (55) and were concentrated by precipitation with ammonium sulfate at 350 mg/ml. Protein concentration was determined by using the Bradford assay. Protein blot and the immuno-detection with ECL (Amersham) were done according to the protocol provided by Amersham.
RESULTS
Localization of the prp4-l, prp4-2 and prp4-3 temperaturesensitive mutations A set of ten (subsequently nine) ts complementation groups was isolated many years ago by random mutagenesis of yeast strain A364A, followed by screening for the inability to accumulate RNA at the non-permissive temperature (49) . The fundamental defect in many members of this class of mutants proved subsequently to lie in mRNA splicing (56) . PRP4 is among this set of genes (49, 56) . It is a component of die U4 snRNP (44, 46) and has a region of intriguing similarity to /3-transducin proteins (37) . Our aim was to establish functionally essential 
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(1) Deletion of the first 9 amino acids and insertion of 2 amino acids (Met-Gly) resulting from the addition of an Ncol site.
(2) Deletion of amino acids # 99 to 108 and insertion of 2 amino acids (Gly and Ser in between) in order to get an fiomHI site (GGATCC). (3) Deletion of the first 108 amino acids and insertion of 4 amino acids (Met-Ala-Gly-Ser) resulting from flushing the BamBl site and addition of an Ncol linker to prp4-\S. si refers to slow growth regions of the PRP4 gene product, as well as specifically to investigate the /3-transducin region. As a beginning, the nucleotide sequence of three existing mutant alleles, prp4-l, -2 and -3, (49) was determined (see Materials and Methods). Theprp4-l mutant gene was rescued from the chromosome of the original strain (obtained from the Yeast Genetic Stock Center, Berkeley; see Materials and Methods) and its entire length was sequenced on both strands. The other two mutations, prp4-2 and prp4-3, obtained directly from L.Hartwell, were derived from the genome of the original mutant isolates (49) by using PCR, and were sequenced. As is described in Materials and Methods, the gene fragments of prp4-2 and prp4-3 that were recovered from the chromosome did not contain the first 80 codons; this was done in order to deal with a fragment of practical size for the PCRmediated recovery, and because the first 108 amino acids are not essential for PRP4 function (see below). The positions of prp4-l, -2 and -3 are shown in Fig. la 
Isolation of site-directed and random point mutations
We obtained additional mutations in the /3-transducin-like region by site-directed mutagenesis, targeting three of the most conserved residues (H306, D328 and W334; 37) and changing each of them to four different amino acids. Fig. lb shows in more detail the amino acid sequence of the five repeats of this region of the PRP4 protein; the consensus amino acids and the locations of changes due to the PRP4 site-directed mutations in the region are indicated. Surprisingly, eight of twelve amino acid changes in these highly conserved residues produced no detectable growth phenotype. The only noticeable changes were due to D328R or D328K (ts or slow growth; prp4-10, -11), W334L (slow growth; prp4-15), and W334P (no-growth; prp4-14).
In addition, we obtained nine single-point mutations by using random mutagenesis (see Materials and Methods). Fig. la shows the distribution of these mutations on the PRP4 protein. Six of those that displayed a ts or null phenotype are located in the portion of the gene that corresponds to the /3-transducin-like or central region of the protein, indicating the importance of these two regions. Three of the mutations that showed a wild-type phenotype were obtained by separating double mutations that were obtained through random mutagenesis. It is striking that none of the mutations fell in the region of the gene that encodes the amino-terminal region of the protein, suggesting that all or part of this region might not be essential for PRP4 function (see also below).
Isolation of prp4 deletion mutations
The results described above suggested that the amino-terminal segment of PRP4 might be non-essential, in contrast to the carboxy-terminal portion. We obtained further evidence on this point by constructing deletion mutations. Fig. 2 and Table 1 show the distribution of these and the phenotypes conferred by them.
Deletion of the amino-terminal 108 amino acids (prp4-34) or subsets of them (prp4-32, -33) had no effect on cell growth at any temperature. In particular, precise deletion of the stretch of acidic amino acids that lies between residues 99 and 108 (prp4-33) yielded normal PRP4 function (data not shown). However, a deletion that reached to residue 142 (prp4-35) was lethal for growth, indicating that at least part of the region of PRP4 that lies between residues 108 and 142 is essential for function. In contrast to the amino-terminus, the carboxy-terminus of PRP4 was much more sensitive to deletion. Loss of as little as one residue from the PRP4 gene product (prp4-38) led to slow growth at an elevated temperature; removal of two amino acids (prp4-2I) yielded ts growth at 35 °C. (Note that theprp4-21 mutation, due to a translation stop-codon, results in a deletion of the terminal two residues of the protein.) Removal of nine amino acids (prp4-37) led to temperature sensitivity at 30°C. prp4-30 is a double mutation (Table 1) . It contains a stop codon (W457STOP), which yields essentially the same mutation as prp4-37, and an additional amino acid change (A238T). Separation of the two mutations in prp4-30 showed that A238T did not affect growth at any temperature tested. Yet, when diis 'wild-type' mutation is combined with the W457STOP ts mutation, the double mutant showed a null phenotype. Another pair of mutations, prp4-21 (W464STOP) and prp4-19 (W464STOP and D240N), showed a similar phenomenon-while prp4-21 displayed a ts phenotype at 35°C, the double mutant (prp4-19) showed a null phenotype but a strain carrying only D240N (prp4-20) was wild-type. These results suggest that the amino-terminal and carboxy-terminal regions of the /3-transducin-like domain might interact-the former can tolerate some amino acid changes, but not in the context of changes to the latter.
The /3-transducin-like region of PRP4 extends to the carboxyterminus of the protein (37) . The mutations discussed so far lie in four of the five repeat-regions (excepting the third). In order to test whether the third of these repeats is also essential for function, it was deleted precisely from the PRP4 gene product (prp4-36) . This destroyed PRP4 function, suggesting that each repeat contains at least one essential residue. This result also implies that other repeat regions cannot substitute for the absence of the third repeat, or that a minimum of five repeats is necessary.
Splicing defects in PRP4 mutants in vivo
The defect in prp4-l mutant strains has been attributed directly to a defect in mRNA splicing (56) . We determined whether the conditional-lethal mutations that were isolated in the present study were unable to splice RNA in vivo. Following a period of exponential growth at room temperature, cells were shifted to non-permissive conditions (37 °C) for 3 h. Total RNA was extracted and was analyzed by primer-extension for the presence of unspliced precursors of U3 snRNA, which contains an mRNAtype of intron (55) . As can be seen in Fig. 3A , in addition to prp4-l (lanes 3, 4), prp4-ll (lanes 5, 6), -21 (lanes 7, 8) and -37 (lanes 9,10) showed a U3 snRNA splicing defect at the nonpermissive temperature, accumulating both species of U3 primary transcript. Fig. 3B shows the quantitation of the ratios of the total pre-U3 snRNAs to the mature U3 snRNAs. In addition, three null mutations that showed a ts phenotype when they were transferred to a 2-jim-based plasmid (prp4-23-, 25 and -26; see Table 1 ) also were unable to splice U3 snRNA to completion at the non-permissive temperature (unpublished results). Thus, all ts mutants that were isolated in this study showed a splicing defect in vivo at 37°C.
Over-expression of some PRP4 mutant gene products suppresses their own mutant phenotype
It has been demonstrated that over-production of the gene products of at least one conditionally-lethal mutant mRNA splicing gene (prpll-1; 57) can reverse the mutant phenotype. This might be explained by assuming that the mutational defect is in the rate of assembly or stability, due to weak binding of the mutated protein to a complex structure, which can be overcome by enhancing the intracellular concentration of gene product, thus driving assembly. We tested a selection of prp4 mutations, some null and some conditional-lethal, for this effect by increasing gene copy-number by placing them on a high-copy (2-/im) plasmid, or in some cases by transcribing them from the highly inducible GAL10 promoter (pGALlO). Previously we have shown that the cellular level of PRP4 gene product is enhanced when the wild-type gene is present on a 2-/tm plasmid (44) . This was confirmed by immuno-blotting for both mutant and wild- 
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G E K R Figure 1 . Distribution of PRP4 point-mutational changes and phenotypes conferred by them. Point mutations were obtained by random and site-directed mutagenesis (see text); the phenotypes were determined by a plasmid shuffle method as described in Materials and Methods, (a). The upper section indicates the mutations that gave rise to ts or slow-growth phenotypes. The middle section represents the distribution of point mutations that conferred a null phenotype. The lower section shows the distribution of point mutations that gave rise to a wild-type phenotype. Mutations labeled * showed a null phenotype when placed on a CEN-ARS plasmid and a ts phenotype when on a 2-/tm-based plasmid. All the mutations that showed a ts or slow-growth phenotype when on a CEN-ARS plasmid also showed a wild-type phenotype when on a 2-/un-based plasmid. Mutations labelled ** were null when on a CEN-ARS or 2-/im-based plasmid, but became ts when expressed under the control of pGALIO. Italicized numbers refer to prp4 alleles. Fig. 4 , PRP4 levels were higher when the alleles were expressed from 2-iim plasmids (Fig. 4A,  lanes 2, 4, 6 and Fig. 4B, lanes 3, 5, 7 ) than when they were expressed from CEN-ARS plasmids (Fig. 4A, lanes 1, 3, 5 and Fig. 4B, lanes 2, 4, 6 ) regardless of whether they were wildtype or mutant alleles. The only exception is prp4-ll protein, which, although over-expressed when the gene is carried on a 2-nm plasmid, appears to be more unstable than its siblings. As is shown in Table 1 , one of the original ts mutations, prp4-l, when present on a 2-/tm-based plasmid, yielded normal growth at both 30°C and 37°C. A similar result was obtained forprp4-ll andprp4-27. A rather more pronounced effect was obtained with other mutants, such as prp4 -19, -21, -23, -25, -26 and -30 . These changes resulted in either a non-functional phenotype or temperature-sensitivity at 30°C when the mutant gene was carried on a CEN-ARS plasmid, but a ts phenotype when carried on a 2-/tm plasmid. The latter class of plasmids has a higher copynumber than the former, which probably also results in a higher production of gene product. Increased gene product was obtained independently by transcribing prp4-23, -25, and -26 from pG-AL10; these phenotypes were essentially the same as when these alleles were present on a 2-|tm-based plasmid. prp4-17, when over-produced from pGALIO changed from a null phenotype to a ts phenotype, although when the allele was present on a 2-/im plasmid, its phenotype was null (Table 1) . . The primer-extension products were quantitated by using a Phosphorimager (Molecular Dynamics). The ratios of total pre-U3 to mature U3 snRNAs from wild-type and mutant prp4 strains are presented.
These results suggest that the defect in the mutant prp4 gene products that we tested lies in their ability to bind to the U4 or other components of the U4/U6 snRNP; increasing the intracellular protein concentration drives the defective gene product towards association with the snRNP, reversing the conditional-lethal phenotype.
Over-expression of PRP3 suppresses the temperature-sensitive phenotype of prp4-l and prp4-ll We sought to determine whether reversal of the ts or null phenotype of any of the prp4 mutants could be obtained by overproduction of any other component that might be expected to interact with the PRP4 gene product. A good candidate is PRP3, since elevated copy-number of this gene has been shown to suppress the ts phenotype due to theprp4-l,-2 and -3 alleles (58). Furthermore, anti-PRP3 antibody can precipitate the U4/U6 snRNP (J.Woolford, personal communication), indicating that PRP3 is one of its components. A CEN-ARS plasmid that carried PRP3 under the control of the pGALW (pYXl 12; see Materials and Methods) was introduced into host strain YF1582 (PRP4::HIS3), which also harboured a plasmid that carried various prp4 ts alleles. Individual colonies of these strains were streaked on solid, selective growth medium containing either 2% glucose (repression of PRP3) or 2% galactose (induction of PRP3) and were incubated at 23°C, 30°C or 37°C. For experiments with non-functionalprp4 mutants, pYXl 12 (pGAL-PRP3) was introduced into host strains that carried both wildtype and mutant PRP4 genes on different plasmids, the wild-type being on a URA3 plasmid; the transformants were tested on galactose-5-F0A agar, which selected for cells that express PRP3 and have lost the PRP4-URA3 plasmid.
As is shown in Fig. 5 , prp4-l (S320F) andprp4-ll (D328R) were suppressed by over-production of the PRP3 gene product (see sectors 4-lb and 4-llb in the figure), in agreement with earlier findings (58); prp4-2/prp4-3 (K272E) could also be suppressed under these conditions (data not shown). However, none of the other twelve mutations that gave a ts or null phenotype on a CEN-ARS plasmid could be suppressed in this way. It is noteworthy that pGAL-PRP3 could not suppress any null alleles of the PRP4 gene, regardless of their location in the gene. This suggests strongly that PRP3 does not substitute for PRP4, but rather compensates for defective PRP4 by interacting with it. A second observation of importance is that of all the prp4 alleles Nucleic Acids Research, 1994 , Vol. 22, No. 9 1731 RT 30°C 35°C 37°C Figure 6 . Suppression by over-production of U6 snRNA of the phenotypes due to three prp4 mutations. Strains carrying prp4-ll, 21 or 24 were transformed with control plasmid YEP24 (a) or pYXl 17 YEP24 carrying the U6 snRNA gene (b). Transformants were grown on His-Leu-Ura drop-out solid medium and were then streaked on the same medium for growth at different temperatures.
tested, the only ones that can be suppressed by increased PRP3 protein lie in the /3-transducin-like repeat region of the protein. This is compatible with the suggestion that the PRP3 and PRP4 proteins interact with one another, and that certain alterations in the PRP4 protein (particularly in the region of amino acids 272 and 320-328) render it unfavourable for binding to PRP3.
Enhancing the intracellular concentration of PRP3 by transcription of that gene from pGALW might drive it to association with certain PRP4 proteins that are partially debilitated in function. Many of the other mutationally altered PRP4 proteins are either incapable of associating with PRP3 under any circumstances, even when they are over-produced, or if they can associate they are non-functional for other reasons.
Over-expression of U6 snRNA partially relieves the phenotype of some prp4 mutants U4 snRNA and U6 snRNA were tested for over-productionreversal of the phenotypes due to prp4 mutants. The U4 snRNA gene when carried on a 2-/tm plasmid failed to reverse the ts phenotypes due toprp4-l, -11, 21 and 24; apGAL10-dri\en U4 snRNA also did not suppress theprp4-l ts phenotype. Subsequent experiments (data not shown) indicated that the intracellular content of U4 snRNA was not increased under these conditions, perhaps due to rapid degradation of over-produced, free snRNA. Consequently, this line of investigation was not pursued further. In contrast, additional U6 snRNA gene copy-number (carried on a 2-/tm plasmid) partially reversed the ts phenotypes due to prp4-ll and -21 (Fig. 6 , sectors 4-1 lb and 4-2 lb) and alsoprp4-l (data not shown), but not of any others. In these strains the relative intracellular amount of U6 snRNA was noticeably reduced at the non-permissive temperature and addition of a plasmid that carried the 2-^m-U6 plasmid reversed this; results for prp4-11 are shown in Fig. 7 . This suggests that some mutant PRP4 proteins lead to destabilization of U6 snRNA, perhaps by rendering the U6 snRNA susceptible to RNase degradation; overproduction of U6 snRNA might partially reverse this effect by enhancing snRNP assembly.
DISCUSSION
We have isolated and characterized point and deletion mutations in the Saccharomyces cerevisiae PRP4 gene, which is part of the U4/U6 snRNP (43, 44) , an essential component of the mRNA splicing apparatus. Analysis of some of these (including three of the original isolates; 49), consisting of nine ts and slowgrowing mutations, six null and eleven wild-type alleles, suggests the following conclusions about the PRP4 protein.
First, the PRP4 protein consists of three major domains. Domain I, the amino-terminal 108 residues, is entirely unnecessary for the function of the protein under any growth conditions that we have used. No random mutations were recovered in this region, and its outright deletion has no growth phenotype. In particular, a stretch of ten amino acids (residues 99-108), whose acidic nature might have suggested a function, is non-essential.
P3TPRP41
wMmmar Active Form Figure 8 . Hypothetical assembly pathway of some U4/U6 snRNP components. Pathways labelled a, b and a', b' represent two alternatives. In the former PRP3 and PRP4 combine before assembling with the U4 snRNA; in the latter assembly of PRP4 with U4 snRNA occurs before the addition of PRP3. It should be noted that the order of addition of U6 snRNA is also not known-it could combine with U4 snRNA before either PRP3 or PRP4. Domain II, the central portion of the protein from residue 109 to 252, which shows no similarity to any other known protein, is essential for function. We have isolated two null phenotype point mutations in this region: E151K (prp4-17) and G193E (prp4 -22) . Neither was suppressible by over-expression of any other U4/U6 snRNP component that we tested, including U6 snRNA and the mutant proteins themselves, although E151K can be partially self-suppressed if over-produced from pGALlO. Deletion of the protein from its amino-terminus up to residue 142 resulted in a null phenotype, confirming the importance of domain II.
Domain II has a region that is relatively rich in arginine and lysine residues (amino acids 135-156). Might this region have a function? If one assumes an a-helical structure for this region, then four arginine residues can be seen to be aligned on one face of the helix, and two lysine and one arginine residues lie on a face immediately adjacent to it (unpublished observations). The available data show that PRP4 is associated primarily with the 5'-stem-loop of U4 snRNA (45, 46) , although no evidence yet shows that PRP4 binds RNA directly. However, if indeed PRP4 does bind to U4 snRNA, either singly or cooperatively with another protein, then perhaps it is through the arginine-lysinerich region noted above. The binding of Tat protein to Tar RNA in HTV is reminiscent of this mechanism of RNA-protein interaction (59) . In support of this suggestion, we note that the phenotype of at least one conditional-lethal mutation in the 5'-stem-loop of U4 snRNA can be suppressed by over-production of PRP4 (Hu et al., submitted), suggesting interaction of PRP4 and U4 snRNA.
Domain HI is the /3-transducin-like region of the protein, consisting of amino acids 252-465. About thirty mutations are located in this domain. Mutations occur as frequently in nonconserved as in conserved residues of the /3-transducin-like motif. Even the most highly conserved residues show surprising plasticity; this is probably not due to redundancy of function, since deletion of one complete repeat is lethal. One of the most highly conserved residues in the repeat region, D328 (37) , an acidic amino acid, can tolerate a substitution of either another acidic amino acid, E, or a neutral one, G, but not a positively charged one, K or R, indicating the importance of charge at this locus. In contrast, H306, also very highly conserved in the repeat regions of both PRP4 and /3-transducins (37), can be altered to any of at least four other amino acids, positively or negatively charged, neutral, with a small side-chain or a large one; possibly higher-order structure plays a larger role than charge or sidechain size of this particular conserved amino acid. The third highly conserved site that was studied in some detail, W334, is also susceptible to phenotypic change due to mutation. Substitution of another aromatic amino acid, F, or loss of the aromatic side-chain by substitution of S or L, has no serious effect. On the other hand, introduction of a proline residue in the region that theoretically could form an a-helix crippled the protein. Again, this suggests the importance of secondary structure rather than charge in this region of the protein.
The second general conclusion regarding PRP4 rests on our observations of phenotypic suppression of certain prp4 mutations. These results can be summarized as follows, (a) Over-production of almost all prp4 mutant alleles, either through elevated genedosage or by enhanced transcription from pGALW, reduced the severity of the particular phenotype associated with them: null phenotypes became conditional, ts phenotypes became either less temperature-sensitive or pseudo-wild-type. This suggests that increasing the intracellular concentration of a defective PRP4 protein might drive it toward association with the U4 or U4/U6 snRNP, reversing the conditional-lethal phenotype. (b) Suppression by over-production of the PRP3 gene product was observed with only three prp4 alleles, prp4-l, prp4-2/4-3 and prp4-ll, which lead to amino changes at residues 320, 272 and 328, respectively. However the phenotypes due to several other prp4 mutants with changes in the /3-transducin-like region could not be reversed in this way. This is compatible with interaction of PRP3 and PRP4; certain alterations to PRP4 in the regions of amino acids 272, 320 and 328 appear to render it unable to interact with PRP3. (c) The phenotypes due to prp4-l, -11, plus prp4-21 (deletion of the carboxy-terminal amino acid), were weakly suppressed by elevated dosage of the U6 snRNA gene. In these mutants growth at the non-permissive temperature led to a decrease in the cellular amount of U6 snRNA, which could be restored by supplying additional copies of the U6 snRNA gene on a plasmid. This suggests that some mutant PRP4 proteins lead to destabilization of U6 snRNA, perhaps by rendering the U6 snRNA susceptible to RNase degradation; over-production of U6 snRNA might partially reverse this effect by enhancing snRNP assembly. Fig. 8 shows a scheme that attempts to account for some of these results. We assume that elevated gene-dosage leads to elevated level of gene product. We note that both PRP4 (44) and PRP3 (J.Woolford, personal communication) are components of the U4/U6 snRNP. The scheme shown in Fig. 8 supposes that moderation of phenotype by over-production of gene product occurs through (partial) restoration of assembly or stability of a complex structure (the snRNP or the spliceosome). The genetic results thus reflect interactions among PRP4, PRP3, U4 snRNA and U6 snRNA.
Over-production of U6 snRNA can partially reverse the phenotypes due to three prp4 mutations that lie in the /3-transducin region (Fig. 6 and unpublished observatons) . It is known that U6 snRNA in a splicing extract is sensitive to degradation by RNase H and micrococcal nuclease digestion (45) . Apparently in some mutant prp4 strains the defective PRP4 protein results in destabilization of the U4/U6 complex, perhaps exposing the U6 snRNA to intracellular nuclease attack, as is suggested in Fig. 8 . Overproduction of U6 snRNA might simply enhance the U6 snRNA pool, driving U4/U6 interaction, thus protecting U6 snRNA.
